Topcon Healthcare, RadiusXR and Glaukos (GKOS) announced a new collaboration and the launch of RadiusXR’s new wearable vision testing platform – Inspire. This collaboration unites RadiusXR’s visual field platform and Topcon Healthcare’s obotic diagnostics and digital healthcare solutions with Glaukos’ patient access by democratizing the diagnosis of ophthalmic diseases such as glaucoma. Together, the companies aim to expand access and enable doctors to provide visual field exams and education to 100% of glaucoma patients who need this important test.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GKOS:
- Glaukos’s Strong Market Position and Growth Prospects Justify Buy Rating
- FDA gives Glaukos ‘Day 74’ notice for Epioxa NDA to treat keratoconus
- Glaukos Corp. Reports Record Sales in Earnings Call
- Glaukos price target raised to $176 from $149 at Needham
- Glaukos price target raised to $160 from $153 at Wells Fargo